Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eric Moessinger
AddedMar 31, 2024
UpdatedMay 31, 2026
Eric Moessinger

Eric Moessinger

Board Member, SQZ Biotechnologies

CrunchbaseLinkedIn

Eric Moessinger's Career

SQZ Biotechnologies
SQZ Biotechnologies

Watertown, MA, US

Board Member· Board
Serotiny
Serotiny

San Francisco, CA, US

Board Member· Board
Visby Medical
Visby Medical

San Jose, CA, US

Board Member· Board
Emulate
Emulate

Boston, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eric Moessinger's Career

SQZ Biotechnologies
SQZ Biotechnologies
$229.8M1132013Watertown, MA, US
Board Member· Board

Leadership at SQZ Biotechnologies

Garry NicholsonGarry NicholsonBoard Member
Zafi AvnurZafi AvnurBoard Member
Bob LangerBob LangerCo-Founder
Klavs JensenKlavs JensenCo-Founder
Marc EliaMarc EliaBoard Member
Pushkal GargPushkal GargBoard Member
Serotiny
Serotiny
Seed$3.1M362014San Francisco, CA, US
Board Member· Board

Leadership at Serotiny

Colin FarlowColin FarlowCo-Founder
Justin FarlowJustin FarlowCo-Founder

Similar to Serotiny

Serinus BiosciencesSerinus BiosciencesNew York City, NY, USCancer Therapiesest. 2022Serinus BiosciencesNew York City, NY, US · est. 2022

Serinus Biosciences: AI-driven precision cancer therapy design to outsmart treatment resistance.

Pre-Seed · $500k6
AI ProteinsAI ProteinsBoston, MA, USProtein Therapeuticsest. 2021AI ProteinsBoston, MA, US · est. 2021

AI Proteins: A biotech firm specializing in the design and engineering of synthetic mini protein therapeutics.

Series B · $18.2M44
Profluent BioProfluent BioBerkeley, CA, USProtein Designest. 2022Profluent BioBerkeley, CA, US · est. 2022

Profluent Bio: An AI-driven firm specializing in designing innovative proteins for industry use.

Seed · $9M4
BigHat BiosciencesBigHat BiosciencesSan Mateo, CA, USTherapeuticsest. 2019BigHat BiosciencesSan Mateo, CA, US · est. 2019

BigHat: Leveraging AI to engineer advanced protein therapeutics for complex diseases.

Series B · $99.3M92
Visby Medical
Visby Medical
Series E$375.1M2732012San Jose, CA, US
Board Member· Board

Leadership at Visby Medical

Donald LaceyDonald LaceyBoard Member
Scott MendelScott MendelBoard Member
Adam de la ZerdaAdam de la ZerdaFounder
Ittai HarelIttai HarelBoard Member
Emulate
Emulate
Series E$224.3M1192013Boston, MA, US
Board Member· Board

Leadership at Emulate

Jim CorbettJim CorbettBoard Member
Sharon KedarSharon KedarBoard Member
Daniel LevnerDaniel LevnerBoard Member
Donald IngberDonald IngberBoard Member
Aaron VanDevenderAaron VanDevenderBoard Member
Martin MadausMartin MadausBoard Member

Similar to Emulate

eGenesiseGenesisCambridge, MA, USGene Editing, Organsest. 2015eGenesisCambridge, MA, US · est. 2015

eGenesis: Revolutionizing transplantation with a gene editing platform for human-compatible organs.

Series C · $265M105
Systemic BioSystemic BioHouston, TX, USOrgans-On-Chipsest. 2022Systemic BioHouston, TX, US · est. 2022

Systemic Bio leverages 3D technology to create bioprinted organs-on-chips for advanced drug discovery.

Seed · $15M11
BiomedInnovationsBiomedInnovationsDenver, NC, USMedical Devicesest. 2015BiomedInnovationsDenver, NC, US · est. 2015

BiomedInnovations: Pioneering tech for long-term storage and interaction with human tissues/organs.

Angel · $250k12
VivoSim LabsVivoSim LabsSan Diego, CA, USBioprinting, Medical Researchest. 2011VivoSim LabsSan Diego, CA, US · est. 2011

Innovative San Diego-based company specializing in 3D bioprinting for medical research and therapy.

Public · $112.3M39

People Similar to Eric Moessinger

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao